oxcarbazepine has been researched along with Disease Models, Animal in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (14.71) | 18.2507 |
2000's | 14 (41.18) | 29.6817 |
2010's | 12 (35.29) | 24.3611 |
2020's | 3 (8.82) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Banach, M; Borowicz-Reutt, K; Rudkowska, M; Sumara, A | 1 |
Bojar, H; Florek-Łuszczki, M; Marzęda, P; Plewa, Z; Wróblewska-Łuczka, P; Załuska-Ogryzek, K; Zolkowska, D; Łuszczki, JJ | 1 |
Aroni, S; Marrosu, F; Melis, M; Milioli, G; Muntoni, AL; Parrino, L; Pillolla, G; Pistis, M; Puligheddu, M; Sagheddu, C; Terzano, GM | 1 |
Nieoczym, D; Socała, K; Szafarz, M; Wlaź, P; Wyska, E | 1 |
Arora, T; Bhowmik, M; Khanam, R; Vohora, D | 1 |
Ahmed, Z; Baker, D; Baker, MD; Coffey, P; Giovannoni, G; Jackson, SJ; Lidster, K; Munro, P | 1 |
Cárdenas-Rodríguez, N; Carmona-Aparicio, L; Coballase-Urrutia, E; Floriano-Sánchez, E; Montesinos-Correa, H; Ortega-Cuellar, D; Rivera-Espinosa, L; Romero-Toledo, A; Sampieri, A | 1 |
Kim, TH; Petrou, S; Reid, CA | 1 |
Florek-Luszczki, M; Kondrat-Wrobel, MW; Luszczki, JJ; Zolkowska, D | 1 |
Antkiewicz-Michaluk, L; Czuczwar, SJ; Luszczki, JJ; Raszewski, G | 1 |
Czuczwar, SJ; Filip, D; Luszczki, JJ | 1 |
Bošković, B; Poznanović, G; Prostran, MŠ; Stepanović-Petrović, RM; Tomić, MA; Ugrešić, ND; Vučković, SM | 1 |
Agarwal, NB; Agarwal, NK; Mediratta, PK; Sharma, KK | 1 |
Alfaro-Rodríguez, A; Arch-Tirado, E; Ávila-Luna, A; Bueno-Nava, A; González-Piña, R; Uribe-Escamilla, R; Vargas-Sánchez, J | 1 |
Argumosa, A; Herranz, JL | 1 |
Czuczwar, SJ; Luszczki, JJ | 3 |
Czuczwar, SJ; Luszczki, JJ; Patsalos, PN; Ratnaraj, N | 1 |
Andres, MM; Czuczwar, SJ; Luszczki, JJ | 1 |
Andres, MM; Cioczek-Czuczwar, A; Czuczwar, P; Czuczwar, SJ; Luszczki, JJ; Patsalos, PN; Ratnaraj, N | 1 |
Bosković, B; Prostran, MS; Stepanović-Petrović, RM; Tomić, MA; Ugresić, N; Vucković, SM | 1 |
Ayala-Guerrero, F; Campos-Sepúlveda, E; González-Maciel, A; Mexicano, G; Reynoso-Robles, R; Romero, RM | 1 |
Bosković, B; Paranos, SLj; Prostran, MS; Stepanović-Petrović, RM; Tomić, MA; Ugresić, ND; Vucković, SM | 1 |
Czuczwar, SJ; Danysz, W; Luszczki, JJ | 1 |
Biri, AA; Cansu, A; Coskun, ZK; Erdogan, D; Giray, SG; Korucuoglu, U; Serdaroglu, A | 1 |
Bosković, B; Kocev, N; Prostran, MS; Stepanović-Petrović, RM; Tomić, MA; Ugresić, ND; Vucković, SM | 1 |
Feldmann, KF; McLean, MJ; Olpe, HR; Portet, C; Schmutz, M; Wamil, AW | 1 |
Blum, D; Fisher, R | 1 |
Andreatini, R; Beijamini, V; Joca, SR; Skalisz, LL | 1 |
White, HS | 1 |
Tecoma, ES | 1 |
Andreatini, R; Beijamini, V; Joca, SR; Skalisz, LL; Vital, MA | 1 |
6 review(s) available for oxcarbazepine and Disease Models, Animal
Article | Year |
---|---|
Modulation of antioxidant enzymatic activities by certain antiepileptic drugs (valproic acid, oxcarbazepine, and topiramate): evidence in humans and experimental models.
Topics: Animals; Anticonvulsants; Antioxidants; Carbamazepine; Disease Models, Animal; Enzymes; Fructose; Humans; Oxcarbazepine; Oxidative Stress; Topiramate; Valproic Acid | 2013 |
[Characteristics and indications of oxcarbazepine].
Topics: Animals; Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Epilepsy; Humans; Ion Channels; Molecular Structure; Oxcarbazepine; Placebos; Treatment Outcome | 2002 |
Oxcarbazepine: mechanisms of action.
Topics: Action Potentials; Animals; Anticonvulsants; Carbamazepine; Cells, Cultured; Disease Models, Animal; Electroshock; Hippocampus; Humans; Neural Conduction; Neurons; Oxcarbazepine; Rodentia; Seizures; Spinal Cord | 1994 |
Clobazam, oxcarbazepine, tiagabine, topiramate, and other new antiepileptic drugs.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Carbamazepine; Clinical Trials as Topic; Clobazam; Disease Models, Animal; Epilepsy; Fructose; Humans; Nipecotic Acids; Oxcarbazepine; Rats; Tiagabine; Topiramate | 1995 |
Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs.
Topics: Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Epilepsies, Partial; Felbamate; Fructose; Humans; Isoxazoles; Lamotrigine; Nipecotic Acids; Oxcarbazepine; Phenylcarbamates; Propylene Glycols; Receptors, GABA; Sodium Channels; Synaptic Transmission; Tiagabine; Topiramate; Triazines; Vigabatrin; Zonisamide | 1999 |
Oxcarbazepine.
Topics: Adult; Animals; Anticonvulsants; Biological Availability; Biotransformation; Carbamazepine; Controlled Clinical Trials as Topic; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Epilepsy; Humans; Oxcarbazepine; Phenytoin; Treatment Outcome | 1999 |
28 other study(ies) available for oxcarbazepine and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Amiodarone Enhances Anticonvulsive Effect of Oxcarbazepine and Pregabalin in the Mouse Maximal Electroshock Model.
Topics: Amiodarone; Animals; Anticonvulsants; Avoidance Learning; Behavior, Animal; Brain; Disease Models, Animal; Electroshock; Epilepsy; Mice; Oxcarbazepine; Pregabalin | 2021 |
Interactions among Lacosamide and Second-Generation Antiepileptic Drugs in the Tonic-Clonic Seizure Model in Mice.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Electroshock; Epilepsy; Lacosamide; Lamotrigine; Male; Mice; Oxcarbazepine; Pregabalin; Seizures; Topiramate | 2021 |
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy.
Topics: Adult; Animals; Anticonvulsants; Benzodiazepines; Carbamazepine; Clobazam; Disease Models, Animal; Drug Resistant Epilepsy; Drug Therapy, Combination; Electroencephalography; Epilepsy, Frontal Lobe; Female; Fenofibrate; Humans; Lamotrigine; Levetiracetam; Male; Mice; Mice, Transgenic; Middle Aged; Mutation; Oxcarbazepine; Piracetam; Polysomnography; PPAR alpha; Receptors, Nicotinic; Triazines; Valproic Acid; Young Adult | 2017 |
Acute effect of cannabidiol on the activity of various novel antiepileptic drugs in the maximal electroshock- and 6 Hz-induced seizures in mice: Pharmacodynamic and pharmacokinetic studies.
Topics: Animals; Anticonvulsants; Brain; Cannabidiol; Chromatography, High Pressure Liquid; Disease Models, Animal; Drug Interactions; Drug Resistant Epilepsy; Electric Stimulation; Gabapentin; Lacosamide; Lamotrigine; Levetiracetam; Male; Mice; Oxcarbazepine; Pregabalin; Seizures; Tiagabine; Topiramate | 2019 |
Oxcarbazepine and fluoxetine protect against mouse models of obsessive compulsive disorder through modulation of cortical serotonin and CREB pathway.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Carbamazepine; Cerebral Cortex; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Fluoxetine; Male; Mice; Obsessive-Compulsive Disorder; Oxcarbazepine; Selective Serotonin Reuptake Inhibitors; Serotonin; Signal Transduction | 2013 |
Neuroprotection in a novel mouse model of multiple sclerosis.
Topics: Animals; Anticonvulsants; Carbamazepine; Caspase 2; Disease Models, Animal; Evoked Potentials, Visual; Green Fluorescent Proteins; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Ophthalmoscopy; Optic Nerve; Optic Neuritis; Oxcarbazepine; Receptors, Antigen, T-Cell; Retina; Retinal Ganglion Cells; RNA Interference; Tomography, Optical Coherence | 2013 |
Oxcarbazepine and its active metabolite, (S)-licarbazepine, exacerbate seizures in a mouse model of genetic generalized epilepsy.
Topics: Animals; Anticonvulsants; Brain; Brain Waves; Carbamazepine; Dibenzazepines; Disease Models, Animal; Epilepsy, Generalized; Humans; Mice; Mice, Transgenic; Mutation; Oxcarbazepine; Receptors, GABA-A; Valproic Acid | 2015 |
Influence of MPEP (a selective mGluR5 antagonist) on the anticonvulsant action of novel antiepileptic drugs against maximal electroshock-induced seizures in mice.
Topics: Animals; Anticonvulsants; Brain; Carbamazepine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Electroshock; Excitatory Amino Acid Antagonists; Fructose; Lamotrigine; Male; Mice; Oxcarbazepine; Pregabalin; Pyridines; Random Allocation; Receptor, Metabotropic Glutamate 5; Seizures; Topiramate; Triazines | 2016 |
Interactions of 1-methyl-1,2,3,4-tetrahydroisoquinoline with lamotrigine, oxcarbazepine, pregabalin, and topiramate in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis.
Topics: Animals; Anticonvulsants; Avoidance Learning; Carbamazepine; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Electroshock; Fructose; gamma-Aminobutyric Acid; Lamotrigine; Male; Memory; Mice; Oxcarbazepine; Pregabalin; Seizures; Tetrahydroisoquinolines; Topiramate; Triazines | 2010 |
Additive interactions of pregabalin with lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis for non-parallel dose-response relationship curves.
Topics: Animals; Carbamazepine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Electroshock; Fructose; gamma-Aminobutyric Acid; Lamotrigine; Male; Mice; Oxcarbazepine; Pregabalin; Psychomotor Performance; Seizures; Topiramate; Triazines | 2010 |
Pharmacological interaction between oxcarbazepine and two COX inhibitors in a rat model of inflammatory hyperalgesia.
Topics: Animals; Carbamazepine; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Interactions; Hyperalgesia; Inflammation; Male; Oxcarbazepine; Rats; Rats, Wistar | 2011 |
Effect of lamotrigine, oxcarbazepine and topiramate on cognitive functions and oxidative stress in PTZ-kindled mice.
Topics: Animals; Anticonvulsants; Carbamazepine; Catalase; Cognition Disorders; Disease Models, Animal; Drug Interactions; Escape Reaction; Fructose; Glutathione; Kindling, Neurologic; Lamotrigine; Male; Malondialdehyde; Maze Learning; Mice; Oxcarbazepine; Oxidative Stress; Pentylenetetrazole; Seizures; Superoxide Dismutase; Topiramate; Triazines | 2011 |
Effects of oxcarbazepine on monoamines content in hippocampus and head and body shakes and sleep patterns in kainic acid-treated rats.
Topics: Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Dopamine; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Kainic Acid; Male; Oxcarbazepine; Rats; Rats, Wistar; Seizures; Serotonin; Sleep Stages | 2011 |
Isobolographic and subthreshold methods in the detection of interactions between oxcarbazepine and conventional antiepileptics--a comparative study.
Topics: Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Electroshock; Male; Mice; Motor Skills; Oxcarbazepine; Seizures | 2003 |
Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis.
Topics: Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Electroshock; Epilepsy; Felbamate; Fructose; Humans; Lamotrigine; Lethal Dose 50; Male; Mice; Neurotoxicity Syndromes; Oxcarbazepine; Phenylcarbamates; Propylene Glycols; Seizures; Topiramate; Triazines | 2004 |
Pharmacodynamic and pharmacokinetic interaction studies of loreclezole with felbamate, lamotrigine, topiramate, and oxcarbazepine in the mouse maximal electroshock seizure model.
Topics: Animals; Anticonvulsants; Behavior, Animal; Carbamazepine; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Electroshock; Felbamate; Fructose; Kindling, Neurologic; Lamotrigine; Male; Mice; Motor Activity; Oxcarbazepine; Phenylcarbamates; Propylene Glycols; Seizures; Topiramate; Triazines; Triazoles | 2005 |
Synergistic interaction of gabapentin and oxcarbazepine in the mouse maximal electroshock seizure model--an isobolographic analysis.
Topics: Amines; Animals; Anticonvulsants; Brain; Carbamazepine; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Electroshock; Gabapentin; gamma-Aminobutyric Acid; Male; Mice; Oxcarbazepine; Psychomotor Performance; Seizures | 2005 |
Isobolographic characterisation of interactions among selected newer antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model.
Topics: Amines; Animals; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Gabapentin; gamma-Aminobutyric Acid; Male; Mice; Motor Activity; Nipecotic Acids; Oxcarbazepine; Pentylenetetrazole; Seizures; Tiagabine | 2005 |
Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
Topics: Animals; Anticonvulsants; Behavior, Animal; Brain; Carbamazepine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Electroshock; Epilepsy; Humans; Levetiracetam; Male; Memory; Mice; Motor Activity; Oxcarbazepine; Piracetam; Seizures | 2006 |
The effects of alpha2-adrenoceptor agents on anti-hyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory pain.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Analgesics, Non-Narcotic; Animals; Carbamazepine; Concanavalin A; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Male; Oxcarbazepine; Pain Threshold; Rats; Rats, Wistar; Treatment Outcome | 2006 |
Effect of oxcarbazepine pretreatment on convulsive activity and brain damage induced by kainic acid administration in rats.
Topics: Animals; Anticonvulsants; Behavior, Animal; Brain; Carbamazepine; Disease Models, Animal; Epilepsy; Excitatory Amino Acid Agonists; Kainic Acid; Male; Oxcarbazepine; Rats; Rats, Wistar | 2008 |
The involvement of peripheral alpha 2-adrenoceptors in the antihyperalgesic effect of oxcarbazepine in a rat model of inflammatory pain.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Carbamazepine; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Inflammation; Male; Oxcarbazepine; Pain; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2 | 2007 |
Interactions of MRZ 2/576 with felbamate, lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model.
Topics: Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electroshock; Felbamate; Fructose; Injections, Intraperitoneal; Lamotrigine; Male; Mice; Oxcarbazepine; Phenylcarbamates; Phthalazines; Propylene Glycols; Receptors, N-Methyl-D-Aspartate; Seizures; Topiramate; Triazines | 2008 |
Effects of chronic treatment with valproate and oxcarbazepine on ovarian folliculogenesis in rats.
Topics: Animals; Anticonvulsants; Apoptosis; Carbamazepine; Corpus Luteum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Epilepsy, Tonic-Clonic; Female; Immunohistochemistry; Lymphotoxin-alpha; Ovarian Follicle; Ovary; Oxcarbazepine; Rats; Rats, Wistar; Valproic Acid | 2008 |
GABAergic mechanisms are involved in the antihyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory hyperalgesia.
Topics: Analgesics, Non-Narcotic; Animals; Anticonvulsants; Bicuculline; Carbamazepine; Concanavalin A; Disease Models, Animal; Dose-Response Relationship, Drug; GABA Antagonists; GABA Modulators; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Hyperalgesia; Inflammation; Injections, Intraperitoneal; Male; Oxcarbazepine; Pain Threshold; Rats; Rats, Wistar | 2008 |
The effect of oxcarbazepine on behavioural despair and learned helplessness.
Topics: Animals; Anticonvulsants; Behavior, Animal; Carbamazepine; Depression; Disease Models, Animal; Helplessness, Learned; Male; Motor Activity; Oxcarbazepine; Rats; Rats, Wistar | 1998 |
The antidepressive-like effect of oxcarbazepine: possible role of dopaminergic neurotransmission.
Topics: Animals; Antidepressive Agents; Apomorphine; Carbamazepine; Catalepsy; Disease Models, Animal; Dopamine Antagonists; Haloperidol; Male; Neurotransmitter Agents; Oxcarbazepine; Rats; Rats, Wistar; Receptors, Dopamine; Stereotypic Movement Disorder; Swimming | 2000 |